Rare-earth oxyorthosilicate scintillator growth stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current scintillator materials and detectors face challenges in achieving improved optical characteristics, such as light output, decay time, and mechanical stability, with high concentrations of defects and macroscopic flaws, limiting their performance in applications like medical imaging and particle physics.

Innovation Solution

Co-doping rare-earth oxyorthosilicate scintillators with a rare-earth activator like Ce and a Group-7 element, specifically Mn or Re, during the crystal growth process to achieve stable growth and optimized scintillation performance parameters, including adjustable fluorescence decay times and reduced defects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional scintillator growth methods are used, then crystal growth can be achieved, but optical characteristics are poor with high defect concentrations and macroscopic flaws

Engineering Contradiction:
Improveoptical characteristicsVSAvoiddefect concentration
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by modifying the chemical composition parameters of the scintillator material through co-doping with specific elements (Ce, Pr, Tb, Eu, or Yb) and adjusting doping concentrations to optimize optical characteristics and reduce defects during crystal growth

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses composite materials by combining rare-earth oxyorthosilicate base material with multiple dopant elements (activator and Group-7 element) to create a composite scintillator system that achieves both structural stability and improved optical properties

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If single-crystal scintillators are produced, then detection performance can be improved, but mechanical stability and optical clarity are compromised due to cracks and macro defects

Engineering Contradiction:
Improvedetection performanceVSAvoidmechanical stability
Core Design Contradiction:
Measurement precisionVSStrength

Solution Approach 1:

The patent introduces intermediary substances (dopant elements Ce, Pr, Tb, Eu, or Yb combined with Group-7 elements) that act as mediators during crystal growth to control defect formation, reduce cracks, and enhance both mechanical stability and optical clarity while maintaining detection performance

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If doping levels are increased to improve scintillation performance, then light output and decay time characteristics are optimized, but growth stability is compromised

Engineering Contradiction:
Improvescintillation performanceVSAvoidgrowth stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by precisely controlling doping concentration parameters and establishing specific ratio relationships between different dopants to achieve optimal scintillation performance while maintaining growth stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements feedback control by monitoring and adjusting doping levels and growth conditions based on observed crystal quality and scintillation characteristics to maintain stable growth while optimizing performance parameters

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The co-doping approach results in scintillators with enhanced optical clarity, reduced defects, and tunable decay times, enabling the production of large, high-quality single crystals with improved light output and reduced afterglow, suitable for advanced medical imaging and other applications.

Implementation Method 1

Scintillator materials, which emit light pulses in response to impinging radiation

Methodology Applied
Scientific EffectScintillation: Scintillation

Implementation Method 2

co-doping of an activator, such as Ce, and a Group-7 element (IUPAC notation), in particular Mn or Re

Methodology Applied
Scientific EffectDoping: Dopants

Data Source

PatentUS9328288B2Rare-earth oxyorthosilicates with improved growth stability and scintillation characteristics
Publication Date: 2016.05.03 SIEMENS MEDICAL SOLUTIONS USA INC
  • US9328288B2 patent drawing
  • US9328288B2 patent drawing
  • US9328288B2 patent drawing

AI summary

A method for making a rare-earth oxyorthosilicate scintillator single crystal includes growing a single crystal from a melt of compounds including a rare-earth element (such as Lu), silicon and oxygen, a compound including a rare-earth activator (such as Ce), and a compound of a Group-7 element (such as Mn). The method further includes selecting an scintillation performance parameter (such as decay), and based on the scintillation performance parameter to be achieved, doping activator and Group-7 element at predetermined levels, or relative levels between the two, so as to achieve stable growth of the single-crystalline scintillator material from the melt.